Jul 2026· Letters in Applied Microbiology· Vol 79· 0 citations
Medicine
TL;DR
While microbial production of glucosamine offers clear environmental and economic advantages, their large-scale feasibility depends on addressing these challenges through integrated approaches, including CRISPR-based gene editing and metabolic engineering and process optimization.
Abstract
Glucosamine and its derivatives have been extensively used in the nutraceutical, cosmetic, food and pharmaceutical industries. Commercial glucosamine production traditionally relies on the acid or enzymatic hydrolysis of crustacean shells, particularly those of shrimp and crabs. However, these processes are often associated with high production costs, environmental concerns, extensive chemical usage, and the generation of hazardous waste. In recent years, microbial production of glucosamine has emerged as a sustainable and environmentally friendly alternative, offering advantages such as milder processing conditions, reduced chemical inputs, and improved process scalability. Microbial approaches include direct glucosamine biosynthesis by native microorganisms, bioconversion of chitin-rich substrates by chitinolytic microbes, and metabolic engineering of recombinant strains for enhanced production. This review explores microbial approaches for glucosamine production, including direct biosynthesis, chitin bioconversion, and recombinant microbial systems. Key challenges related to substrate utilization, process scalability, strain stability, and product recovery are critically evaluated, along with emerging solutions involving metabolic engineering and process optimization. Additionally, strategies to overcome such challenges such as CRISPR-based gene editing, optimization of culture and fermentation conditions etc. have been discussed. This review emphasizes the fact that while microbial production of glucosamine offers clear environmental and economic advantages, their large-scale feasibility depends on addressing these challenges through integrated approaches.
Kojic acid is an industrially important fungal secondary metabolite widely utilised in the cosmetic, pharmaceutical, and food industries due to its tyrosinase inhibitory, antioxidant, and metal-chelating properties. The increasing commercial demand for naturally derived kojic acid is constrained by limitations associat...
Parth Shroff, Darshan Marjadi· Journal of Advances in Biolo...· 0 citations
Xylitol is a five-carbon sugar alcohol widely used in the food, pharmaceutical, oral healthcare, and personal care industries because of its low caloric value, low glycaemic index, and non-cariogenic properties. Industrial production is mainly based on catalytic hydrogenation of xylose, which provides high conversion e...
This review provides the current state of PHAs production from wild yeast strains and the various approaches that have been used to improve yield, and discusses the performance, challenges, and limitations of various synthetic biology and metabolic engineering strategies in yeast strains for PHAs production.
K. Mohanrasu, R. Selvakumar, I. Grainge et al.· International Journal of Bio...· 0 citations
The escalating global population and the environmentally inefficient nature of livestock-based protein production are intensifying demand for sustainable and scalable protein alternatives. Microbial biosynthesis, employing engineered cell factories, represents a pivotal strategy for producing functional proteins with a...
Zewei Lu, Zhuoer Chen, Dianqi Yang et al.· Comprehensive Reviews in Foo...· 0 citations
Terpenoids (isoprenoids) constitute one of the largest and most structurally diverse families of natural products with application ranging from flavors, pharmaceuticals to biofuels. Conventional extraction from plants is often limited by low yields, seasonal variability, and environmental constraints; whereas, chemical...
Vibha Shukla, V. Shukla, Shweta Rawat et al.· Frontiers in Bioengineering...· 0 citations
Artificial intelligence (AI) and machine learning (ML) have emerged as powerful tools for metabolic engineering by enabling pathway prediction, metabolic flux optimization, enzyme engineering, and identification of bottlenecks throughout terpenoid biosynthesis.
Aakash Kamalesan, K. Kumar, Bharathi Nathan et al.· Antonie van Leeuwenhoek· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.